FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.9.1  |  FHIR Version n/a  User: [n/a]

900000000000523009: POSSIBLY EQUIVALENT TO association reference set (foundation metadata concept)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001150016 POSSIBLY EQUIVALENT TO association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001151017 POSSIBLY EQUIVALENT TO association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)

49161 members. Search Members:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
POSSIBLY EQUIVALENT TO association reference set (foundation metadata concept) Is a Historical association reference set (foundation metadata concept) true Inferred relationship Some
Members targetComponentId
Dropped beats - heart QRS complex dropped
Dropped beats - heart Premature beats
Drops dose form Oral solution
Droxidopa 100mg capsule Droxidopa 100 mg oral capsule
Droxidopa 200mg capsule Product containing precisely droxidopa 200 milligram/1 each conventional release oral capsule (clinical drug)
Droxidopa 300mg capsule Product containing precisely droxidopa 300 milligram/1 each conventional release oral capsule (clinical drug)
Drug &/or toxic polyneuropathy Toxic polyneuropathy
Drug AND/OR toxin-induced diarrhea Infectious diarrheal disease
Drug AND/OR toxin-induced diarrhea Diarrhea caused by drug
Drug Rx stopped - end of trial Drug treatment stopped at end of clinical trial (situation)
Drug addict: [notific to CMO] or [HS2A 1(Rev) to HO] Drug addiction notification
Drug addict: [notific to CMO] or [HS2A 1(Rev) to HO] Drug addiction notification
Drug addict: [renotif to CMO] or [renotif-HS2A to HO] Drug addiction notification
Drug addict: [renotif to CMO] or [renotif-HS2A to HO] Drug addiction notification
Drug addiction notification Drug addiction notification
Drug addiction notification (& admin) Drug addiction notification
Drug allergen Substance
Drug allergy Allergy to drug
Drug allergy Allergic reaction to drug
Drug and heavy metal Heavy metal
Drug and heavy metal Drug or medicament (substance)
Drug builder Drug excipient
Drug dependence: [absinthe] or [other specified] Absinthe addiction
Drug dosage medication Drug dosage education (procedure)
Drug dose form Basic dose form (basic dose form)
Drug dose form Pharmaceutical dose form (dose form)
Drug emulsion Emulsion
Drug for the treatment of gout adverse reaction Colchicum alkaloid adverse reaction
Drug for the treatment of gout adverse reaction Colchicine adverse reaction
Drug for the treatment of gout adverse reaction Uricosuric agent adverse reaction
Drug groups primarily affecting the cardiovascular system Pharmaceutical / biologic product (product)
Drug hypersensitivity Allergy to drug
Drug induced: [agranulocytosis] or [neutropenia] Drug-induced neutropenia
Drug lotion Lotion (basic dose form)
Drug lotion, 0,025% Lotion (basic dose form)
Drug lotion, 0,05% Lotion (basic dose form)
Drug lotion, 0,1% Lotion (basic dose form)
Drug lotion, 0,25% Lotion (basic dose form)
Drug lotion, 0,5% Lotion (basic dose form)
Drug lotion, 1% Lotion (basic dose form)
Drug lotion, 2,5% Lotion (basic dose form)
Drug measurement Measurement of substance (procedure)
Drug monitoring not required Medication monitoring not indicated
Drug not taken - pat disbelief Drugs not taken/completed
Drug or toxin Toxin
Drug or toxin Drug or medicament (substance)
Drug overdose Overdose
Drug overdose of undetermined intent Overdose
Drug paste Paste
Drug paste, 0,5% Paste
Drug photoallergic response Drug-induced photosensitivity
Drug powder Powder (basic dose form)
Drug powder and solvent Powder (basic dose form)
Drug prescription Medicinal prescription record
Drug prescription Prescription of drug
Drug product - agent for migraine Medicinal product acting as antimigraine agent (product)
Drug reaction - anti-inflammatory analgesic Non-steroidal anti-inflammatory drug adverse reaction (disorder)
Drug reaction - anti-inflammatory analgesic Non-steroidal anti-inflammatory drug adverse reaction (disorder)
Drug reaction - endocrine NOS Adverse reaction to hormone
Drug reaction - endocrine NOS Adverse reaction to hormone
Drug reaction - endocrine drug Adverse reaction to hormone
Drug reaction - endocrine drug Adverse reaction to hormone
Drug resistant Streptococcus pneumoniae Penicillin resistant Streptococcus pneumoniae (organism)
Drug resistant Streptococcus pneumoniae Multiple drug-resistant Streptococcus pneumoniae (organism)
Drug screen Measurement of substance (procedure)
Drug screening test Measurement of substance (procedure)
Drug screening test Measurement of substance (procedure)
Drug screening test Measurement of substance (procedure)
Drug solution Solution
Drug suspension Suspension
Drug therapy Drug therapy (procedure)
Drug therapy Chemotherapy
Drug therapy (& intramuscular injection) Chemotherapy
Drug therapy (& intramuscular injection) Drug therapy (procedure)
Drug therapy Drug therapy (procedure)
Drug therapy Chemotherapy
Drug therapy stopped (& on medical advice) Drug therapy discontinued (situation)
Drug therapy stopped (& on medical advice) Drug treatment stopped - medical advice
Drug therapy stopped (& on medical advice) Drug therapy discontinued (situation)
Drug therapy stopped (& on medical advice) Drug treatment stopped - medical advice
Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions Drug-induced tubulointerstitial nephritis (disorder)
Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions Heavy-metal-induced tubulointerstitial nephritis (disorder)
Drug-induced contact dermatitis Contact dermatitis
Drug-induced diffuse interstitial pulmonary fibrosis Interstitial pulmonary fibrosis due to inhalation of drug
Drug-induced glaucoma Open angle glaucoma caused by drug (disorder)
Drug-induced glaucoma Angle closure glaucoma caused by drug (disorder)
Drug-induced intensive care psychosis Drug-induced psychosis
Drug-induced nausea AND/OR vomiting Drug-induced nausea and vomiting (disorder)
Drug-induced paranoia or hallucinatory state NOS Hallucinosis caused by drug
Drug-induced paranoia or hallucinatory state NOS Paranoid state caused by drug (disorder)
Drug-induced paranoia or hallucinatory states Hallucinosis caused by drug
Drug-induced paranoia or hallucinatory states Paranoid state caused by drug (disorder)
Drug: [hypersensitivity NOS] or [adverse reaction NOS] or [allergic reaction NOS] or [idiosyncrasy NOS] Allergy to drug
Drugs for strongyloidiasis Antiparasitic-containing product
Drugs for trichomonacides Antiprotozoal agent
Drugs used in infections Medicinal product acting as antiinfective agent (product)
Drugs used in malignant disease and for immunosuppression Antineoplastic agent
Drugs used in malignant disease and for immunosuppression Medicinal product acting as immunosuppressant (product)
Drugs used in megaloblastic anemias Medicinal product acting as antianemic agent (product)
Drugs used in the eye Product manufactured as ocular dose form (product)
Drugs used to treat hyperactivity disorders Central stimulant

Start Previous Page 161 of 492 Next End

Reference Sets

Reference set descriptor

GB English

US English

Back to Start